This protocol is judged by an institutional assessment board, an unbiased team that evaluations any medical trials involving individuals. If a examine will involve a Routine I drug, as soon as the board approves the protocol as ethical, the researchers have to make an application for an investigational new drug (IND) number with the FDA.And since